Explained: After UK, Scotland Too Bans Puberty Blockers For Under 18, Know What It Means

Recently on December 11, the British government indefinitely banned puberty blockers for children with gender dysphoria. This step was taken after independent experts found that there was an unacceptable safety risk involved when prescribing this medication.

Before getting into the "why" of the ban, let's understand what gender dysphoria is and what puberty blockers do.

Gender Dysphoria

As per the National Health Service (NHS), UK, gender dysphoria is a term that describes a sense of unease that a person may have because of a mismatch between their biological sex and their gender identity. The NHS writes, "Most people identify as "male" or "female". These are sometimes called "binary" identities. However, some people feel their gender identity is different from their biological sex. For example, some people may have male genitals and facial hair but do not identify as a male or feel masculine."

NHS notes that children show their interest through the choice of toys and clothes that are often associated "societally" with the opposite gender.

Puberty Blocker

They are a type of medication that delays the changes of puberty in gender-diverse youth. They are called gonadotrophin-releasing hormone (GnRH).

How does it work?

Sex hormones get affected once you consume this medicine. Sex hormones determine the sexual organs present at birth, which are also known as the primary sex characteristics. They include the penis, scrotum and testicles, and the uterus, ovaries and vagina. In contrast, the secondary sex characters are the organs or physical changes that occur in our body after we hit puberty. For instance, facial hair, development of breasts, etc.

So what do puberty blockers do?

It delays puberty, which can combat the symptoms, as noted by NHS, which can occur if someone experiences gender dysphoria. The symptoms include:

• low self-esteem
• becoming withdrawn or socially isolated
• depression or anxiety
• taking unnecessary risks
• neglecting themselves

The puberty blocker by delaying the development of secondary sex character helps with the:

• improving mental well-being
• ease depression and anxiety
• improve social interactions with others
• lower the need for future surgeries
• ease thoughts or actions of self-harm

So, why is it banned?

The UK stated that this decision will be revisited in 2027, till then the ban remains effective. However, it goes against standards held by medical groups including the European and World Professional Associations for Transgender Health and American Medical Association and the American Academy of Pediatrics.

The ban was put in place by the Conservative government and has been extended by the Labour government too. The announcement comes after a judge upheld an emergency ban in a ruling that said this treatment could be potentially harmful. However, NHS also stopped prescribing puberty blockers at gender identity clinics stating that there was not enough evidence found for either benefits or harms.

However, in July, Justice Beverley Lang said that the review commissioned by the NHS found "very substantial risks and very narrow benefits” to the treatment. The confusion exists because the British Medical Association further noted that the NHS review was controversial and included patients, academics, scientists and legal experts among its critics. However, the group that challenged the court - TransActual criticized the decision and said that evidence of danger from 40 years of puberty blocker cannot be tracked.

Banning medicines with no evidence of serious harm, only for trans people … is discrimination plain and simple,” said Keyne Walker, the group’s strategy director. “Evidence of the harm of the temporary ban continues to emerge, and will grow now that it has been made permanent.”

Why the ban in Scotland?

The Scottish government also confirmed that as the medicine policy is reserved to Westminster, the ban would also apply across England, Scotland and Wales.

However, the ban is not on those who are already consuming the medicine for gender dysphoria, but on the "new children and young people aged under 18 years from beginning to take puberty blockers for the purposes of gender incongruence and/or gender dysphoria. under the care of private or non-UK prescribers".